$59.83
+1.85 (+3.18%)
Performance
1D
+0.00%
1W
-0.21%
1M
+12.16%
3M
+21.69%
6M
+38.68%
1Y
+85.56%
YTD
+104.32%
Open$57.99
Previous Close$57.98
Day High$60.82
Day Low$57.55
52W High$63.60
52W Low$26.76
Volume—
Avg Volume1.91M
Market Cap8.87B
P/E Ratio20.10
EPS$2.75
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$55.80
Above
SMA 200
$44.53
Above
RSI (14)
67.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+4.3% upside
Current
$59.83
$59.83
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 566.41M | 1.04B | 1.08B |
| Net Income | 410.98M | 129.57M | 136.18M |
| Profit Margin | 72.6% | 12.5% | 12.7% |
| EBITDA | 113.40M | 169.61M | 170.48M |
| Free Cash Flow | — | 110.01M | 140.89M |
| Rev Growth | +504.9% | +16.6% | +24.3% |
| Debt/Equity | 1.10 | 0.33 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |